GSK to acquire Aiolos Bio for US$ 1 billion upfront payment
Acquisition expands GSK’s respiratory pipeline adding AIO-001, a phase II-ready, long-acting antibody targeting the clinically validated TSLP pathway
Acquisition expands GSK’s respiratory pipeline adding AIO-001, a phase II-ready, long-acting antibody targeting the clinically validated TSLP pathway
Arco Lab now holds a 50% stake in Neviton
Lays Foundation Stone of 6 new facilities at AIIMS Bhopal and inaugurates a slew of facilities in Madhya Pradesh
The deal includes upfront payments, milestone payments and ongoing royalties
The clearance of this audit marks the successful registration of 8 APIs with CADIFA
Star Health's convenient claims process, valued added offerings like free telemedicine consultations with expert doctors
The company has received five final approvals
The company received gross proceeds of approximately US$1.7 million and net proceeds,
Subscribe To Our Newsletter & Stay Updated